Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Determination of the Efficacy and Safety of Psoralait Versus Placebo in the Treatment of Psoriasis.

NCT01149252 is registered in ClinicalTrials.gov with Trima, Israel Pharmaceutical Products as lead sponsor.

NCT NCT01149252
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01149252 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Determination of the Efficacy and Safety of Psoralait Versus Placebo in the Treatment of Psoriasis.
Lead sponsor
Trima, Israel Pharmaceutical Products
Phase
Phase 4
Overall status
Terminated
Start date
January 31, 2011
Completion date
March 31, 2013
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis